Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Ankle Sprain
SUPPORT 2
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Diclofenac Sodium Patch for the Topical Treatment of Acute Pain Due to Mild to Moderate Ankle Sprain
1 other identifier
interventional
219
1 country
1
Brief Summary
The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium topical patch in reducing acute pain due to mild to moderate ankle sprains when applied to the painful area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Feb 2009
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 24, 2009
CompletedFirst Posted
Study publicly available on registry
March 25, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedJanuary 28, 2010
January 1, 2010
4 months
March 24, 2009
January 26, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in average pain during daily activity at Day 3
Day 3
Secondary Outcomes (1)
Change in average pain during daily activity at Day 7
Day 7
Study Arms (2)
Diclofenac Sodium Patch
EXPERIMENTALTopical Placebo Patch
PLACEBO COMPARATORInterventions
Topical diclofenac patch applied once daily to area of pain
Matching placebo patch, containing identical constituents to the active comparator except for diclofenac sodium; applied once daily
Eligibility Criteria
You may qualify if:
- Male and female subjects 17 - 75 years of age
- Sustained recent, painful unilateral mild to moderate ankle sprain
- Meet baseline pain criterion
You may not qualify if:
- Open wound or infection at site of injury
- Evidence of severe injury or ankle fracture
- Use of oral NSAIDs or opioids within 12 - 24 hours of injury
- Presence or history of peptic ulcers or GI bleeding
- A history of intolerance to NSAIDs, acetaminophen, adhesives
- Positive pregnancy test
- Positive drug screen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cerimon Pharmaceuticalslead
- PPD Development, LPcollaborator
Study Sites (1)
PPD
Austin, Texas, 78704, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
March 24, 2009
First Posted
March 25, 2009
Study Start
February 1, 2009
Primary Completion
June 1, 2009
Study Completion
August 1, 2009
Last Updated
January 28, 2010
Record last verified: 2010-01